About SPORTIVO Network
0 Comments
0 Shares
707 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Immunotherapy Drugs Market Research Report by End-Use IndustryAccording to the latest report published by Data Bridge Market Research, the Immunotherapy Drugs Market The global immunotherapy drugs market size was valued at USD 251.94 billion in 2024 and is expected to reach USD 601.87 billion by 2032, at a CAGR of 11.50 % during the forecast period The large scale Immunotherapy Drugs Marketing report studies and evaluates market drivers,...0 Comments 0 Shares 202 Views 0 Reviews
-
Oncolytic Virus Immunotherapy Market: Trends and Growth Opportunities 2025 –2032Executive Summary Oncolytic Virus Immunotherapy Market: Share, Size & Strategic Insights CAGR Value The global oncolytic virus immunotherapy market size was valued at USD 3.71 billion in 2025 and is expected to reach USD 9.18 billion by 2033, at a CAGR of12.00% during the forecast period Oncolytic Virus Immunotherapy Market research report works best for...0 Comments 0 Shares 1K Views 0 Reviews
-
Advancements in Immunotherapy Boosting the US Cancer Vaccines Market Through 2031Advancements in immunotherapy have revolutionized cancer treatment by introducing innovative solutions that harness the body’s immune system to fight malignant cells. Among these innovations, cancer vaccines are gaining prominence as they offer targeted therapeutic and preventive capabilities. Overview of Cancer Vaccines Market InsightsThe Cancer Vaccines Market Insights highlight a...0 Comments 0 Shares 2K Views 0 Reviews
-
Allergy Immunotherapy Market Growth, Trends, DROT, Analysis & Forecast Analysis By FMIAllergy Immunotherapy Market Expands Beyond Symptom Relief as Long-Term Immune Modulation Gains Ground in Global Allergy Care NEWARK, DE / According to the latest analysis by Future Market Insights, the Allergy Immunotherapy Market is emerging as a critical segment within long-term allergy management, as healthcare systems increasingly shift from temporary symptom control toward...0 Comments 0 Shares 464 Views 0 Reviews
-
Allergy Immunotherapy Market Size Projected to Reach USD 5.66 Billion by 2035“According to a new report published by Introspective Market Research, Allergy Immunotherapy Market by Treatment Type, Allergy Type, and Distribution Channel, The Global Allergy Immunotherapy Market Size Was Valued at USD 2.26 Billion in 2024 and is Projected to Reach USD 5.66 Billion by 2035, Growing at a CAGR of 8.70%.” Allergy Immunotherapy (AIT), often referred to as allergy...0 Comments 0 Shares 2K Views 0 Reviews
-
Beyond IgG: The Next Frontier in Immunotherapy and Antibody EngineeringFor decades, Immunoglobulin G (IgG) has been the undisputed heavyweight champion of therapeutic antibodies. From treating chronic autoimmune diseases to revolutionizing oncology with immune checkpoint inhibitors, IgG molecules have dominated the biologics market. Their long serum half-life, ease of manufacturing, and well-understood biology made them the logical first choice for researchers....0 Comments 0 Shares 439 Views 0 Reviews
-
Cancer Immunotherapy Market Dynamics: Drivers, Restraints, Opportunities, and ChallengesThe Cancer Immunotherapy Market is witnessing substantial growth as healthcare systems worldwide increasingly adopt innovative cancer treatment approaches. Immunotherapy has emerged as one of the most promising therapeutic solutions in oncology, offering improved survival rates and targeted treatment options for patients suffering from various forms of cancer. The growing prevalence of cancer,...0 Comments 0 Shares 525 Views 0 Reviews
-
Cancer Treatment Drugs Market to Reach USD 359.83 Billion by 2032 Driven by Immunotherapy and Precision Oncology AdvancementsAccording to a report by Intel Market Research, the global cancer treatment drugs market was valued at USD 193.12 billion in 2024 and is projected to grow from USD 211.45 billion in 2025 to USD 359.83 billion by 2032, exhibiting a CAGR of 9.5% during the forecast period. The market is witnessing strong growth due to the rising global burden of cancer, increasing adoption of targeted therapies...0 Comments 0 Shares 475 Views 0 Reviews
-
Cell-Based Immunotherapy Market Competitive Benchmarking and Industry Outlook"Cell-Based Immunotherapy Market Summary According to the latest report published by Data Bridge Market Research, the Cell-Based Immunotherapy Market The global cell-based immunotherapy market size was valued at USD 5.74 billion in 2025 and is expected to reach USD 23.09 billion by 2033, at a CAGR of 19.01% during the forecast period The reliable...0 Comments 0 Shares 290 Views 0 Reviews
-
Cell-Based Immunotherapy Market : Supply Chain, Pricing, and Forecast 2025 –2032"Future of Executive Summary Cell-Based Immunotherapy Market: Size and Share Dynamics CAGR Value The cell-based immunotherapy market is expected to witness market growth at a rate of 19.01% in the forecast period of 2021 to 2028. Businesses can attain detailed insights with the large scale Cell-Based Immunotherapy Market survey report which help them self-assuredly make decisions...0 Comments 0 Shares 1K Views 0 Reviews
-
Expanding Immunotherapy Use Boosts US Non-Small Cell Lung Cancer Market GrowthThe United States represents the largest contributor to the NSCLC market due to its extensive oncology care network, strong clinical research ecosystem, and high healthcare expenditure. The country continues to witness significant advancements in targeted therapies aimed at specific genetic mutations such as EGFR, ALK, ROS1, and KRAS. Increased utilization of immunotherapy drugs and combination...0 Comments 0 Shares 316 Views 0 Reviews
-
Acquired Hemophilia Treatment Market Analysis by Treatment Type and End UserThe global healthcare industry is increasingly focusing on rare disease management and advanced hematology treatments, creating strong growth opportunities for the acquired hemophilia treatment market. Acquired hemophilia is a rare autoimmune bleeding disorder caused by the development of autoantibodies against clotting factors, particularly factor VIII. The condition can lead to severe...0 Comments 0 Shares 728 Views 0 Reviews
-
Biologic Medications for Psoriasis Market Expanding at 7.8% CAGR from 2026–2034 with Strong Industry AdoptionAccording to a new report from Intel Market Research, the global biologic medications for psoriasis market was valued at USD 14.5 billion in 2025 and is projected to reach USD 28.7 billion by 2034, growing at a CAGR of 7.8% during the forecast period (2026–2034). This growth is fueled by increasing psoriasis prevalence, superior efficacy of biologics over conventional treatments, and...0 Comments 0 Shares 2K Views 0 Reviews
-
Bladder Cancer Market to Reach USD 4.1 Billion by 2031 | CAGR 6.7%According to a newly published market research report by 24LifeSciences, global bladder cancer market was valued at USD 2.6 billion in 2024 and is projected to reach USD 4.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.7% during the forecast period 2025-2031. Bladder cancer remains one of the most prevalent urological malignancies worldwide, with non-muscle invasive...0 Comments 0 Shares 2K Views 0 Reviews
-
Cancer Biologics Market Advances with Growing Adoption of Targeted Therapies and Immuno-Oncology InnovationsAccording to the latest report published by Data Bridge Market Research, the Cancer Biologics Market The global cancer biologics market size was valued at USD 122.55 billion in 2024 and is projected to reach USD 195.62 billion by 2032, with a CAGR of 6.02% during the forecast period of 2025 to 2032. Cancer Biologics Market is the world-class market research report which carries...0 Comments 0 Shares 55 Views 0 Reviews
-
Castleman Disease Drug Market Growth, Pipeline Analysis & Global Forecast"Castleman Disease Drug Market According to the latest report published by Data Bridge Market Research, the Castleman Disease Drug Market The global Castleman Disease drug market was valued at USD 231.78 million in 2024 and is expected to reach USD 342.44 million by 2032 and is projected to grow at a CAGR of 5.0%, primarily driven by the...0 Comments 0 Shares 186 Views 0 Reviews
-
Checkpoint Inhibitor Refractory Cancer Market to Reach USD 8.75 Billion by 2032 | CAGR 9.6%According to a newly published market research report by 24LifeSciences, global checkpoint inhibitor refractory cancer market was valued at USD 4.2 billion in 2024 and is projected to reach USD 8.75 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.6% during the forecast period 2025–2032. Checkpoint inhibitor refractory cancer occurs when tumors develop...0 Comments 0 Shares 2K Views 0 Reviews
More Results
Czech
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek